Life science company Bio-Rad Laboratories has extended its range of recombinant monoclonal anti -idiotypic antibodies. The ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the ...
The Pioneer Platform features a state-of-the-art phage display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of three new StarBright™ Red Dyes—StarBright ...
Hosted on MSN
Bio-Rad Extends Anti-Idiotypic Antibody and SpyCatcher Reagent Ranges for Bioanalysis and Antibody Drug Development
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the ...
The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus. Scientists developing vaccines and therapeutics ...
DUBLIN--(BUSINESS WIRE)--The "Global Markets for Research Antibodies" report has been added to ResearchAndMarkets.com's offering. The global market for research antibodies was valued at approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results